Stock on Watch: BioTime, Inc. (BTX)
- Sunday, May 14, 2017, 21:09
- Stock Market, Stock Research
- Add a comment
Company Profile: |
BioTime, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing products addressing degenerative diseases based on pluripotent stem cells and HyStem cell/drug delivery platform technologies. Its product candidates include Renevia, a facial aesthetics product that is in pivotal clinical trial for the treatment of HIV related facial lipoatrophy; OpRegen, which is in Phase I/IIa clinical trial for the treatment of the dry form of age-related macular degeneration; HyStem-BDNF, a preclinical development program for the delivery of recombinant human brain-derived neurotrophic factor (BDNF) directly into the stroke cavity of patients for aiding in tissue repair and functional recovery; and ReGlyde that is in preclinical development as a device for viscosupplementation and a combination product for drug delivery in osteoarthritis. BioTime, Inc. was founded in 1990 and is based in Alameda, California. |
Recent News: |
On May 10, 2017, the company reported net Income (loss) attributable to BioTime: Net income attributable to BioTime was $49.3 million, or $0.46 per basic and diluted common share for the three months ended March 31, 2017, compared to net loss of $17.1 million, or ($0.19) per basic and diluted common share. |
Fundamental Analysis: |
Ninestocks analyzes several different financial aspects: Growth, Profitability, solvency and efficiency. |
Growth – Measures the growth of both the company’s income statement and cash flow. @@@@@ |
Profitability – Measures the historical price movement of the stock. @@@@@ |
Solvency – Measures the solvency of the company based on several ratios. @@@@@ |
Efficiency – Measures the strength and historic growth of a company’s return on invested capital. @@@@@ |
Conclusion: |
BTX’s strengths can be seen in its strong profitability compared with its peers. Technical indicators signal the bullish signs, as there is a bullish cross in Stochastic Oscillator and RSI stands at 48.42 with positive bias. We rate BioTime, Inc. (BTX) a STRONG BUY. |
About the Author
Write a Comment
Gravatars are small images that can show your personality. You can get your gravatar for free today!
You must be logged in to post a comment.